Literature DB >> 27998511

A comparison of the Work and Social Adjustment Scale (WSAS) across different patient populations using Rasch analysis and exploratory factor analysis.

Gursimran Thandi1, Nicola T Fear2, Trudie Chalder3.   

Abstract

INTRODUCTION: The Work and Social Adjustment Scale (WSAS) is designed to measure patients' perceived functional impairment associated with a health problem. There is a paucity of studies that explore the stability of the item hierarchy in the WSAS across different disease populations. This study investigated the unidimensional structure of the WSAS across different disease populations.
METHODS: Secondary data analysis was conducted on pooled patient data (HIV, breast cancer, and inflammatory conditions) to create a new dataset (n=554). The data were analysed using Rasch analysis and exploratory factor analysis.
RESULTS: Exploratory factor analysis and principle component analysis of the WSAS showed a good fit as a unidimensional scale, person and item separation indices were >2 suggesting that the WSAS is sensitive enough to distinguish between participants of varying levels of ability. Some differential item functioning was seen by diagnosis and by sex for items 1 and 5 of the WSAS.
CONCLUSIONS: Overall, a one dimensional structure was identified for the WSAS. However, a small number of differential item functioning (DIF) was identified, suggesting that scores from the WSAS cannot be compared across groups.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Functional impairment; Rasch analysis; Work and Social Adjustment Scale

Mesh:

Year:  2016        PMID: 27998511     DOI: 10.1016/j.jpsychores.2016.11.009

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  10 in total

1.  Assessing functioning in adolescents with chronic fatigue syndrome: psychometric properties and factor structure of the School and Social Adjustment Scale and the Physical Functioning Subscale of the SF36.

Authors:  M E Loades; S Vitoratou; K A Rimes; T Chalder
Journal:  Behav Cogn Psychother       Date:  2020-04-01

2.  A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.

Authors:  T A Kuut; F Müller; A Aldenkamp; E Assmann-Schuilwerve; A Braamse; S E Geerlings; K B Gibney; R A A Kanaan; P Nieuwkerk; T C Olde Hartman; D Pauëlsen; M Prins; K Slieker; M Van Vugt; C P Bleeker-Rovers; S P Keijmel; H Knoop
Journal:  Trials       Date:  2021-12-02       Impact factor: 2.279

3.  Efficacy of acupuncture based on acupoint combination theory for irritable bowel syndrome: a study protocol for a multicenter randomized controlled trial.

Authors:  Jing-Wen Sun; Ming-Liang Sun; Da Li; Jun Zhao; Su-Hua Shi; Hui-Xia Li; Hui-Min Liu; Jun-Xia Gao; Yu Hu; Hui Zheng; Xin Wang; Rong-Dan Xue; Xue Feng; Shu-Guang Yu; Zhi-Gang Li
Journal:  Trials       Date:  2021-10-19       Impact factor: 2.279

4.  Delivering Mindfulness-Based Interventions for Insomnia, Pain, and Dysfunctional Eating Through a Text Messaging App: Three Randomized Controlled Trials Investigating the Effectiveness and Mediating Mechanisms.

Authors:  Amanda Cm Li; Keith Kl Wong; Floria Hn Chio; Winnie Ws Mak; Loretta Wh Poon
Journal:  J Med Internet Res       Date:  2022-05-03       Impact factor: 7.076

5.  A community-based peer-support group intervention "Paths to EvERyday life" (PEER) added to service as usual for adults with vulnerability to mental health difficulties - a study protocol for a randomized controlled trial.

Authors:  Chalotte Heinsvig Poulsen; Cecilie Høgh Egmose; Bea Kolbe Ebersbach; Carsten Hjorthøj; Lene Falgaard Eplov
Journal:  Trials       Date:  2022-09-02       Impact factor: 2.728

6.  Impact of Rome IV irritable bowel syndrome on work and activities of daily living.

Authors:  Vivek C Goodoory; Cho Ee Ng; Christopher J Black; Alexander C Ford
Journal:  Aliment Pharmacol Ther       Date:  2022-07-06       Impact factor: 9.524

7.  Risk of stress/depression and functional impairment in Denmark immediately following a COVID-19 shutdown.

Authors:  Lars H Andersen; Peter Fallesen; Tim A Bruckner
Journal:  BMC Public Health       Date:  2021-05-26       Impact factor: 3.295

8.  Treatment Adherence as Predictor of Outcome in Concentrated Exposure Treatment for Obsessive-Compulsive Disorder.

Authors:  Kristian Tjelle; Håvard Berg Opstad; Stian Solem; Gunvor Launes; Bjarne Hansen; Gerd Kvale; Kristen Hagen
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

9.  PRO*BPD: effectiveness of outpatient treatment programs for borderline personality disorder: a comparison of Schema therapy and dialectical behavior therapy: study protocol for a randomized trial.

Authors:  Eva Fassbinder; Nele Assmann; Anja Schaich; Kristin Heinecke; Till Wagner; Valerija Sipos; Kamila Jauch-Chara; Michael Hüppe; Arnoud Arntz; Ulrich Schweiger
Journal:  BMC Psychiatry       Date:  2018-10-19       Impact factor: 3.630

10.  Testing non-inferiority of blended versus face-to-face cognitive behavioural therapy for severe fatigue in patients with multiple sclerosis and the effectiveness of blended booster sessions aimed at improving long-term outcome following both therapies: study protocol for two observer-blinded randomized clinical trials.

Authors:  Marieke Houniet-de Gier; Heleen Beckerman; Kimberley van Vliet; Hans Knoop; Vincent de Groot
Journal:  Trials       Date:  2020-01-20       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.